450 filings
Page 16 of 23
424B5
mdy xhl275a
17 Aug 16
Prospectus supplement for primary offering
12:00am
424B5
bspxm02sm 9hob
16 Aug 16
Prospectus supplement for primary offering
12:00am
8-K
wcjd 85k96bvd
12 Aug 16
Recro Pharma Reports Second Quarter 2016 Financial Results
12:00am
8-K
hnaanytk
27 Jul 16
Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam
12:00am
8-K
saj 5duewo95jr
14 Jul 16
Other Events
12:00am
8-K
nur6gitu7r8
5 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
afj83cm u5nd
25 May 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
cvdp3y5
12 May 16
Recro Pharma Reports First Quarter 2016 Financial Results
12:00am
8-K/A
urpqqlk
29 Apr 16
Financial Statements and Exhibits
12:00am
DEFA14A
m5koc
14 Apr 16
Additional proxy soliciting materials
12:00am
8-K
ubv o89lrjdl0ioj7u5
24 Mar 16
Recro Pharma Reports Year End 2015 Financial Results
12:00am
8-K
51msgl
14 Mar 16
Other Events
12:00am
8-K
vdagbym1
22 Feb 16
Results of Operations and Financial Condition
12:00am
8-K
jiy6ei cqi
16 Feb 16
Recro Pharma Appoints Fred Graff as Chief Commercial Officer
12:00am
424B3
og6yhjgoi 31ktqz
12 Feb 16
Prospectus supplement
12:00am
8-K
6n6 0pod1qmqdcng
12 Feb 16
Other Events
12:00am